Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the page template.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study record now indicates that enrollment has ended ('No longer looking for participants') and adds new help/navigation sections: 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also shows a UI text formatting change for 'Intervention/Treatment' and updates the revision banner from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check23 days agoChange DetectedThe page footer revision label updated from v3.5.4 to v3.5.5, indicating a newer site revision.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision identifier updated from v3.5.3 to v3.5.4, indicating a newer version of the page was published. This change represents an internal update to page metadata and QA checks, not a substantive change to study content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a software/release update without changing the displayed study details.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.